Case–Control Study of Clostridium innocuum Infection, Taiwan

Case–Control Study of Clostridium innocuum Infection, Taiwan

Vancomycin-resistant Clostridium innocuum was recently identified as an etiologic agent for antibiotic-associated diarrhea in humans. We conducted a case–control study involving 152 C. innocuum-infected patients during 2014–2019 in Taiwan, using 304 cases of Clostridioides difficile infection (CDI)...

Full description

Bibliographic Details
Main Authors:	Yi-Ching Chen, Yi-Chun Kuo, Mi-Chi Chen, Young-Da Zhang, Chyi-Liang Chen, Puo-Hsien Le, Cheng-Hsun Chiu
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2022-03-01
Series:	Emerging Infectious Diseases
Subjects:	Clostridium innocuum Clostridioides difficile extraintestinal clostridial infection vancomycin resistance antimicrobial resistance bacteria
Online Access:	https://wwwnc.cdc.gov/eid/article/28/3/20-4421_article

Similar Items

Clostridium innocuum, an emerging pathogen that induces lipid raft-mediated cytotoxicity
by: Hui-Yu Wu, et al.
Published: (2023-12-01)

Diversity and Prevalence of Clostridium innocuum in the Human Gut Microbiota
by: Disha Bhattacharjee, et al.
Published: (2023-02-01)

Clostridium difficile appendicitis in an immunocompromised patient: a case report and review of the literature
by: Charles Dac Pham, et al.
Published: (2021-01-01)

Splenic Abscess Caused by Clostridium difficile
by: Chee Yik Chang, et al.
Published: (2023-08-01)

Curcumin: A natural derivative with antibacterial activity against Clostridium difficile
by: Deepansh Mody, et al.
Published: (2020-06-01)

Treatment of Extra-Intestinal Clostridioides difficile Abscess following Acute Appendicitis
by: Tulika Chatterjee, et al.
Published: (2022-09-01)

Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis
by: Mohammad Sholeh, et al.
Published: (2020-09-01)

Fecal microbiota transplantation for treatment of refractory or recurrent Clostridioides difficile infection in Taiwan: a cost-effectiveness analysis
by: Kai-Yen Lan, et al.
Published: (2023-10-01)

Toxin profiles and antimicrobial resistance patterns among toxigenic clinical isolates of Clostridioides (Clostridium) difficile
by: Hamid Heidari, et al.
Published: (2019-07-01)

Inhibition of spores to prevent the recurrence of Clostridioides difficile infection - A possibility or an improbability?
by: Chun-Wei Chiu, et al.
Published: (2021-12-01)

<i>Clostridioides difficile</i> – a new name, the old problems with diagnosis and treatment
by: Sergey M. Zakharenko
Published: (2023-01-01)

Effective Dosage of Oral Vancomycin in Treatment for Initial Episode of <i>Clostridioides difficile</i> Infection: A Systematic Review and Meta-Analysis
by: Chia-Yu Chiu, et al.
Published: (2019-10-01)

Bacteriophages Contribute to Shaping Clostridioides (Clostridium) difficile Species
by: Louis-Charles Fortier
Published: (2018-08-01)

Antimicrobial Resistance of Clostridioides difficile in Children from a Tertiary Pediatric Hospital in Shanghai, China
by: Li X, et al.
Published: (2024-01-01)

Detection and Investigation of Eagle Effect Resistance to Vancomycin in Clostridium difficile With an ATP-Bioluminescence Assay
by: Angie M. Jarrad, et al.
Published: (2018-07-01)

Concomitant Vancomycin-Resistant Enterococcus faecium and Clostridium difficile Colitis
by: Shehriyar Mehershahi, et al.
Published: (2021-03-01)

Ribotypes and antimicrobial susceptibility profiles of clinical Clostridioides difficile isolates: A multicenter, laboratory-based surveillance in Taiwan, 2019–2021
by: Chin-Shiang Tsai, et al.
Published: (2024-04-01)

Clostridium myonecrosis — a rare and underdiagnosed condition in the elderly: a case with severe skipping lesions and an overview of treatment guidelines
by: Ellen Van Asbroeck, et al.
Published: (2022-10-01)

Vancomycin-Resistant Enterococcus faecium Colonization and Clostridium difficile Infection in a Hematologic Patient
by: Ivana Goić-Barišić, et al.
Published: (2020-01-01)

<i>Clostridioides difficile</i> infection in hospital and community settings: summary document of a multidisciplinary group
by: Anna Danise, et al.
Published: (2024-02-01)

Routine Treatment-Resistant Clostridium difficile Infection during Recovery from Myxedema
by: Jan K. Adamski, et al.
Published: (2017-11-01)

Does Fidaxomicin reduce Cure and Recurrence rates compared to Vancomycin in Clostridium Difficile Infection patients?: A Systematic Review and Meta-analysis
by: Hiral N Golakiya, et al.
Published: (2022-06-01)

Low Density Lipoprotein Receptor-Related Protein-1 (LRP1) Is Involved in the Uptake of Clostridioides difficile Toxin A and Serves as an Internalizing Receptor
by: Dennis Schöttelndreier, et al.
Published: (2020-10-01)

The Tip of the Four N-Terminal α-Helices of Clostridium sordellii Lethal Toxin Contains the Interaction Site with Membrane Phosphatidylserine Facilitating Small GTPases Glucosylation
by: Carolina Varela Chavez, et al.
Published: (2016-03-01)

Neutralizing epitopes on Clostridioides difficile toxin A revealed by the structures of two camelid VHH antibodies
by: Baohua Chen, et al.
Published: (2022-11-01)

In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile
by: Dana Binyamin, et al.
Published: (2018-06-01)

Clostridium difficile associated diarrhea, successfully managed with custom prepared oral vancomycin
by: JAMA Jayatilake, et al.
Published: (2022-04-01)

Characteristics of patients infected with Clostridioides difficile at a Saudi Tertiary Academic Medical Center and assessment of antibiotic duration
by: Khadijah M. Alammari, et al.
Published: (2021-02-01)

Treatment of pediatric Clostridium difficile infection: a review on treatment efficacy and economic value
by: D'Ostroph AR, et al.
Published: (2017-10-01)

Editorial: The Deadly Secrets of C. Difficile—Insights Into Host-Pathogen Interaction, Volume II
by: Meina Neumann-Schaal, et al.
Published: (2022-04-01)

Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models
by: John C. Vitucci, et al.
Published: (2020-02-01)

Updated Management Guidelines for <i>Clostridioides difficile</i> in Paediatrics
by: Margherita Gnocchi, et al.
Published: (2020-04-01)

The Clinical Efficacy, Safety, and Tolerability of Vancomycin for the Treatment of Recurrent Clostridioides difficile Infection – A Systematic Review
by: Knudsen MJS, et al.
Published: (2023-03-01)

Risk Factors of Patients With Diarrhea for Having Clostridioides (Clostridium) difficile Infection
by: Vanessa Lang, et al.
Published: (2022-03-01)

Spore-Forming Clostridium (Clostridioides) difficile in Wastewater Treatment Plants in Western Australia
by: Jessica M. Chisholm, et al.
Published: (2023-02-01)

Prolonged oral vancomycin for secondary prophylaxis of relapsing Clostridium difficile infection
by: Kevin Zhang, et al.
Published: (2019-01-01)

Enterococcus faecalis Isolated From Infant Feces Inhibits Toxigenic Clostridioides (Clostridium) difficile
by: Chonticha Romyasamit, et al.
Published: (2020-09-01)

Efficacy of lyophilised bacteria-rich faecal sediment and supernatant with reduced bacterial count for treating patients with Clostridioides difficile Infection – A novel method for capsule faecal microbiota transfer
by: Adorján Varga, et al.
Published: (2023-01-01)

Human and Porcine Transmission of Clostridioides difficile Ribotype 078, Europe
by: Geraldine Moloney, et al.
Published: (2021-09-01)

National Surveillance for Clostridioides difficile Infection, Sweden, 2009–2016
by: Kristina Rizzardi, et al.
Published: (2018-09-01)